Otolaryngology: Pharyngeal Cancer Pharyngeal Cancer PathologySquamous Cell Carcinoma – Most Common Malignant TumorAdenocarcinomaAdenoid Cystic CarcinomaLymphomaRhabdomyosarcomaGeneralMost Have Lymph Node Involvement by the Time of DiagnosisMay Be Associated with Epstein-Barr Virus (EBV) (57%)Titers Can Be Used to Follow Treatment ResponsePresentationNasopharynx:Painless Neck Mass – Most Common Presenting Complaint (60%)From Lymph Node MetastasesNasal ObstructionNasal PainHearing LossReferred Otalgia – EaracheOropharynx:Pain (Odynophagia/Otalgia)DysphagiaObstructive Sleep Apnea/SnoringBleedingNeck MassLymph Node SpreadTo Posterior Cervical Lymph Nodes:NasopharynxOropharynxTo Anterior Cervical Lymph Nodes:HypopharynxDiagnosisInitial Evaluation: Imaging (CT/MRI)Definitive Diagnosis: BiopsyAvoided for Juvenile Nasopharyngeal Angiofibroma (Hemorrhage Risk)General TreatmentEarly-Stage (Stage I-II): Radiation TherapyMay Consider Transoral Resection for Oropharyngeal CancerAdvanced-Stage (Stage III-IV):Nasopharyngeal Cancer: Chemoradiation Therapy (No Surgery)Oropharyngeal Cancer:Surgical Resection & Adjuvant Radiation Therapy (With/Without Chemotherapy)Definitive Chemoradiation Therapy*Basic Indications: > 4 cm, Positive LN or Bony Invasion Juvenile Nasopharyngeal Angiofibroma (JNA) BasicsBenign Vascular Tumor of the NasopharynxThe Most Common Benign Tumor of the NasopharynxMostly in Young Males (10-25 Years Old)High Recurrence Rate (Up to 35%)PresentationNasal ObstructionEpistaxisNasal MassNasal PainDiagnosisPreliminary Diagnosis: CT/MRI“Holman-Miller Sign” – Anterior Bowing of the Posterior Maxillary WallAvoid Biopsy (Risk Life-Threatening Hemorrhage)Definitive Diagnosis Based on Pathology After ResectionTreatmentPrimary Treatment: Surgical ResectionStrongly Consider Preoperative Angioembolization if Moderate-Large Size